Zkusit zdarma
Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc.

LRMR
Cena:
 
 
Valuace
70
Růst
53
Zdraví
75
preloader

Finanční výsledky Larimar Therapeutics, Inc. (LRMR)

Měna: USD

Ukazatel20252024202320222021
Diluted EPS-2.27-1.32-0.84-1.37-2.95
Gross Profit-----
Net Income Attributable to Common Shareholders-165.7M-80.6M-36.9M-35.4M-50.6M
Operating Profit-172.5M-90.9M-41.8M-36.5M-50.5M
Total Revenues-----